Charles Schwab CRO exercises options, sells 32,947 shares
Nigel J. Murtagh, Chief Risk Officer of Charles Schwab, exercised 32,947 nonqualified stock options into common stock at $46.81 per share on July 27, 2026, under the company’s 2013 Stock Incentive Plan.
Rhea-AI Filing Summary
Nigel J. Murtagh, Chief Risk Officer of Charles Schwab, exercised 32,947 nonqualified stock options into common stock at $46.81 per share on July 27, 2026, under the company’s 2013 Stock Incentive Plan. He then sold 21,947 shares at a weighted-average price of $104.00 and 11,000 shares at a weighted-average price of $104.0317 in open-market transactions pursuant to a Rule 10b5-1 trading plan adopted on November 25, 2025.
After these transactions, he reports 15,675 options remaining from this grant and indirect ownership of 2,621 shares through an employee stock purchase plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 32,947 shares ($1.88M approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
Murtagh Nigel J
Role
Chief Risk Officer
Sold
32,947 shs ($3.43M)
Approx. gross sale proceeds
$3.43M
Approx. exercise cost
$1.54M
Approx. pre-tax spread
$1.88M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Nonqualified Stock Option (right to buy) F3 | 32,947 | $0.00 | $0.00 |
| Exercise | Common Stock | 32,947 | $46.81 | $1.54M |
| Sale | Common Stock F1, F2 | 21,947 | $104.00 | $2.28M |
| Sale | Common Stock F2 | 11,000 | $104.0317 | $1.14M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Nonqualified Stock Option (right to buy) — 15,675 contracts (Direct);
Common Stock — 57,972.4846 shares (Direct);
Common Stock — 2,621 shares (Indirect, by ESPP)
Footnotes (3)
- F1. These sales reported in this Form 4 were effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on November 25, 2025.
- F2. This transaction was executed in multiple trades at prices ranging from $103.95 to $104.075. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
- F3. This option was granted under the company's 2013 Stock Incentive Plan and vested in four annual installments beginning on the first anniversary of the grant.
Key Figures
Options exercised: 32,947 shares
Option exercise price: $46.81 per share
Shares sold (lot 1): 21,947 shares at $104.00
+4 more
7 metrics
Options exercised
32,947 shares
Nonqualified stock options exercised into common stock on July 27, 2026
Option exercise price
$46.81 per share
Exercise price for 32,947 options under the 2013 Stock Incentive Plan
Shares sold (lot 1)
21,947 shares at $104.00
Weighted-average sale price in open-market transaction on July 27, 2026
Shares sold (lot 2)
11,000 shares at $104.0317
Weighted-average sale price in additional open-market transaction
Options remaining
15,675 options
Nonqualified stock options remaining from this grant after the exercise
Indirect ESPP holdings
2,621 shares
Common shares held indirectly through an employee stock purchase plan
Option expiration
March 1, 2029
Expiration date of the nonqualified stock option grant exercised
Key Terms
Rule 10b5-l trading plan, Nonqualified Stock Option, weighted average sale price, 2013 Stock Incentive Plan, +1 more
5 terms
Rule 10b5-l trading plan regulatory
"sales were effected pursuant to a Rule 10b5-l trading plan adopted"
Nonqualified Stock Option financial
"security title listed as Nonqualified Stock Option (right to buy)"
A nonqualified stock option (NQSO) is a company grant that gives an individual the right to buy shares at a set price but does not meet special tax rules for incentive stock options; when exercised the difference between the market price and the exercise price is treated as ordinary income for the recipient and as a tax-deductible expense for the company. It matters to investors because NQSOs affect an employee’s after-tax proceeds, the company’s reported expenses, and potential share dilution—think of it like a cash bonus that converts into stock but is taxed as regular pay when you take it.
weighted average sale price financial
"the price reported reflects the weighted average sale price"
2013 Stock Incentive Plan financial
"this option was granted under the company's 2013 Stock Incentive Plan"
ESPP financial
"indirect ownership is reported as by ESPP"
An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did SCHW Chief Risk Officer Nigel Murtagh report in this Form 4?
Nigel Murtagh reported exercising 32,947 stock options at $46.81 per share and then selling 32,947 Charles Schwab (SCHW) common shares in open-market transactions at weighted-average prices of about $104 per share on July 27, 2026.
Were Nigel Murtagh’s SCHW stock sales under a Rule 10b5-1 plan?
Yes. The Form 4 states these sales were effected under a Rule 10b5-1 trading plan adopted by Nigel Murtagh on November 25, 2025, indicating the transactions followed a pre-established, disclosed trading arrangement.
What Charles Schwab (SCHW) equity does Nigel Murtagh still hold after these transactions?
After the reported trades, Nigel Murtagh shows 15,675 stock options remaining from the exercised grant and indirect ownership of 2,621 Charles Schwab (SCHW) shares through an employee stock purchase plan (ESPP), according to the Form 4 holdings table.
What are the key terms of the options Nigel Murtagh exercised at SCHW?
The exercised options covered 32,947 shares at an exercise price of $46.81 per share, were granted under the 2013 Stock Incentive Plan, vested in four annual installments, and have an expiration date of March 1, 2029, as described in the filing footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
